» Articles » PMID: 23962719

Promoter Histone H3K27 Methylation in the Control of IGF2 Imprinting in Human Tumor Cell Lines

Overview
Journal Hum Mol Genet
Date 2013 Aug 22
PMID 23962719
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant imprinting of the insulin-like growth factor II (IGF2) gene is a molecular hallmark of many tumors. Reactivation of the normally suppressed maternal allele leads to upregulation of the growth factor that promotes tumor growth. However, the mechanisms underlying the loss of imprinting (LOI) remain poorly defined. We examined the epigenotypes at the gene promoters that control IGF2 allelic expression. Using chromatin immunoprecipitation, we found that in cells characterized by maintenance of IGF2 imprinting, three IGF2 promoters were differentially modified, with the suppressed allele heavily methylated at histone H3K27 while the active allele was unmethylated. In the LOI tumors, however, both alleles were unmethylated, and correspondingly there was no binding of SUZ12, the docking factor of the polycomb repressive complex 2 (PRC2), and of the zinc finger-containing transcription factor (CTCF) that recruits the PRC2. Using chromatin conformation capture, we found that the CTCF-orchestrated intrachromosomal loop between the IGF2 promoters and the imprinting control region was abrogated in cells with LOI. SUZ12, which docks the PRC2 to IGF2 promoters for H3K27 methylation, was downregulated in LOI cells. These data reveal a new epigenetic control pathway related to the loss of IGF2 imprinting in tumors.

Citing Articles

The role of imprinting genes' loss of imprints in cancers and their clinical implications.

Xie G, Si Q, Zhang G, Fan Y, Li Q, Leng P Front Oncol. 2024; 14:1365474.

PMID: 38812777 PMC: 11133587. DOI: 10.3389/fonc.2024.1365474.


Human IGF2 Gene Epigenetic and Transcriptional Regulation: At the Core of Developmental Growth and Tumorigenic Behavior.

Scalia P, Williams S, Fujita-Yamaguchi Y Biomedicines. 2023; 11(6).

PMID: 37371750 PMC: 10296432. DOI: 10.3390/biomedicines11061655.


Emerging Role of Plant-Based Dietary Components in Post-Translational Modifications Associated with Colorectal Cancer.

Rodriguez-Garcia C, Gutierrez-Santiago F Life (Basel). 2023; 13(2).

PMID: 36836621 PMC: 9962725. DOI: 10.3390/life13020264.


Intrachromosomal Looping and Histone K27 Methylation Coordinately Regulates the lncRNA -Fetal Mitogen Imprinting Cluster in the Decidual Microenvironment of Early Pregnancy.

Wen X, Zhang Q, Zhou L, Li Z, Wei X, Yang W Cells. 2022; 11(19).

PMID: 36231092 PMC: 9563431. DOI: 10.3390/cells11193130.


Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors.

Alexandrova E, Salvati A, Pecoraro G, Lamberti J, Melone V, Sellitto A Front Genet. 2022; 13:864612.

PMID: 35495127 PMC: 9043692. DOI: 10.3389/fgene.2022.864612.


References
1.
Feinberg A . Genomic imprinting and gene activation in cancer. Nat Genet. 1993; 4(2):110-3. DOI: 10.1038/ng0693-110. View

2.
Engel N, Bartolomei M . Mechanisms of insulator function in gene regulation and genomic imprinting. Int Rev Cytol. 2004; 232:89-127. DOI: 10.1016/s0074-7696(03)32003-0. View

3.
Hofmann W, Takeuchi S, Frantzen M, Hoelzer D, Koeffler H . Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells. Exp Hematol. 2002; 30(4):318-23. DOI: 10.1016/s0301-472x(01)00797-4. View

4.
Chen H, Li T, Qiu X, Wu J, Ling J, Sun Z . Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming. EMBO J. 2006; 25(22):5329-38. PMC: 1636609. DOI: 10.1038/sj.emboj.7601399. View

5.
Hu J, Vu T, Hoffman A . Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19. J Biol Chem. 1997; 272(33):20715-20. DOI: 10.1074/jbc.272.33.20715. View